Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States

September 2, 2016 at 8:46 am

mBIO August 30, 2016 V.7 N.4

José R. Mediavillaa, Amee Patrawallab, Liang Chena, Kalyan D. Chavdaa, Barun Mathemac, Christopher Vinnarda, Lisa L. Deverd, Barry N. Kreiswirtha

aPublic Health Research Institute Tuberculosis Center, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA

bDivision of Pulmonary and Critical Care Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA

cDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA

dDivision of Infectious Diseases, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA

Colistin is increasingly used as an antibiotic of last resort for the treatment of carbapenem-resistant Gram-negative infections. The plasmid-borne colistin resistance gene mcr-1 was initially identified in animal and clinical samples from China and subsequently reported worldwide, including in the United States.

Of particular concern is the spread of mcr-1 into carbapenem-resistant bacteria, thereby creating strains that approach pan-resistance. While several reports of mcr-1 have involved carbapenem-resistant strains, no such isolates have been described in the United States.

Here, we report the isolation and identification of an Escherichia coli strain harboring both mcr-1 and carbapenemase gene blaNDM-5 from a urine sample in a patient without recent travel outside the United States.

The isolate exhibited resistance to both colistin and carbapenems, but was susceptible to amikacin, aztreonam, gentamicin, nitrofurantoin, tigecycline, and trimethoprim-sulfamethoxazole.

The mcr-1- and blaNDM-5-harboring plasmids were completely sequenced and shown to be highly similar to plasmids previously reported from China.

The strain in this report was first isolated in August 2014, highlighting an earlier presence of mcr-1 within the United States than previously recognized.

FULL TEXT

http://mbio.asm.org/content/7/4/e01191-16.full

PDF

http://mbio.asm.org/content/7/4/e01191-16.full.pdf+html

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Biología Molecular, Epidemiología, Infecciones urinarias, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update. Tags: .

Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie?


Calendar

September 2016
M T W T F S S
« Aug   Oct »
 1234
567891011
12131415161718
19202122232425
2627282930  

Most Recent Posts


%d bloggers like this: